Microvesicles in sera from patients with acute myeloid leukemia[125] and from hypoxic tumor cells were shown to inhibit natural killer (NK) cells, an effect dependent on vesicular TGF-β transfer[126]. This evidence concerns the gene TGFB1 and neoplasm.